You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR Phase II:Integrated Point-of-Care System for Rapid Pathogen Identification and Characterization
SBC: NANOPATH INC. Topic: BMThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is improved access to state-of-the-art molecular diagnostic technologies in areas of significant unmet clinical need, such as women’s health. During the NSF I-Corps Program, the team identified urinary tract infections (UTIs) as pressing problem due to the currently lengthy clinical workflo ...
SBIR Phase II 2023 National Science Foundation -
Phase II: Redesigning Floriculture Marketplace & Inventory Management Tools for Small Produce Farms to Increase Accessibility and Reduce Cost
SBC: Rooted Farmers, LLC Topic: 812PROPOSAL ABSTRACTPhase II: Redesigning Floriculture Marketplace & Inventory Management Tools for SmallProduce Farms to Increase Accessibility and Reduce CostPD/PIs: Amelia Ihlo Annika Martell Justine McFarlandBackground: Rooted Farmers has developed a dynamic online platform that provides broadregional market access across wholesale and retail channels for small- and mid-sized farms. Ourcurrent pl ...
SBIR Phase II 2023 Department of Agriculture -
A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome
SBC: CELDARA MEDICAL, LLC Topic: NIAIDPROJECT SUMMARY Rodent-borne viral outbreaks are increasing in both frequency and impact. As weather patterns evolve, rodent populations are affected and may multiply in areas where increased contact with humans results in infection. Hantaviruses, including Andes (ANDV) and Sin Nombre (SNV), are transmitted through the excreta of infected rodents and, when aerosolized, infect humans. In the Americ ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline
SBC: SYNCHROHEALTH LLC Topic: NIAPROJECT SUMMARY Clinical Need: Sarcopenia and frailty represent significant and growing clinical challenges whose rates increase with age, and place patients at risk for functional decline, institutionalization, or death. Resistance exercises are strongly recommended in this age group to promote muscle regeneration and strength and are routinely a part of evidence-based home exercise programs pres ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Non-surgical treatment option for pelvic organ prolapse
SBC: REIA LLC Topic: NICHDProject Summary / Abstract Reia is working to address a prevalent gynecological condition, pelvic organ prolapse (POP), which affects more than 50% of women over the age of 50. POP occurs when the pelvic floor connective tissue and muscles weaken, allowing the uterus or vaginal walls to descend. In extreme cases, the uterus descends through the opening of the vagina and hangs outside of the body. ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel Engineered Tendon Graft to Assist in Repair of Rotator Cuff Injuries
SBC: PRO THERAPEUTICS LLC Topic: NIAMSPROJECT SUMMARY/ABSTRACT Introduction: Skeletal Tissue Engineering Laboratories (STEL) Technologies, LLC is a woman-owned, Michigan- based regenerative medicine company founded in 2013. STEL’s first product, the CGEMTM graft, is a unique biological replacement for the anterior cruciate ligament (ACL) injuries. The researchers have since adapted this graft technology with the goal of treating Rot ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes
SBC: CELDARA MEDICAL, LLC Topic: 200Project Summary According to the American Diabetes Association, Type 2 diabetes mellitus (T2D) affects at least 30 million Americans and is a major unmet public health concern with an annual cost in the United States of over $300 billion dollars. Additionally, nearly 25% of the U.S. population is already considered prediabetic, or at high risk of developing T2D. These individuals are characterized ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Non-invasively extendable megaprosthesis
SBC: Granite Medical, LLC Topic: NIAMSABSTRACT This project is the development of a non-invasively extending distal femur replacement (DFR) for children and adolescents subsequent to bone tumor resection. Each year in the US there are 200-250 malignant bone tumor diagnoses in the distal femurs of patients 15 years and younger. With advances in chemotherapy, limb salvage surgery utilizing a megaprosthesis has increasingly become the tr ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Preclinical development of an important, broad-spectrum antibody for pandemic influenza
SBC: CELDARA MEDICAL, LLC Topic: NIAIDHealth and human services (HHS) and the Biomedical Advanced Research and Development Authority (BARDA) have suggested a severe pandemic influenza outbreak is the greatest current threat to national and global security. The Center for Disease Control rates H7N9 as the most threatening of the Influenza A viruses as it, along with H5N1, have fatality rates of ~40% and ~60%, respectively. Models have ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Continuous Correlations for Complete Boiling Curves of Cryogenic Fluids
SBC: CREARE LLC Topic: T14Future space exploration missions will rely on in situ production, storage, and transfer of cryogenic rocket propellants. Engineers need accurate and efficient modeling tools to design the next generation of lightweight, efficient cryogenic propellant management devices and processes. Predictive models for key fluid dynamics and heat transfer behavior must be tailored for use with cryogenic propel ...
STTR Phase II 2023 National Aeronautics and Space Administration